BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the net proceeds from the offering to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are joint book-running managers of the offering.
Public Offering
BioSig intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will be used for gold bullion purchase, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company act as joint book-running managers of the offering.
- The offering is subject to market conditions, with uncertainties regarding timing, size, and terms.
- Investors are advised to read the preliminary prospectus supplement and other relevant documents before investing.
BioSig Technologies' proposed public offering signifies a strategic move to secure funding for gold bullion purchase and corporate purposes.